Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Change in Receivables of -$13000.0 for Q1 2026, down 225.0% sequentially from -$4000.0 in Q4 2025, and up 98.34% YoY from -$6554.6 in Q1 2025.
Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Change in Receivables for 3 years, with the latest figure at -$13000.0 in Q1 2026.
- Quarterly Change in Receivables rose 98.34% year-over-year to -$13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8000.0 (down 200.0% YoY) and the FY2025 annual result came in at -$776000.0, down 198.35% from the prior year.
- Change in Receivables retreated to -$13000.0 in Q1 2026 per CNTB's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $5.0 million in Q3 2024 and troughed at -$4.2 million in Q4 2024.
- A 3-year average of $0.0 and a median of -$8000.0 in 2025 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 99.91% in 2025, down 99.66% in 2025.
- Over 3 years, Change in Receivables stood at -$4.2 million in 2024, then surged by 99.91% to -$4000.0 in 2025, then sank by 225.0% to -$13000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$13000.0, -$4000.0, and $17000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Dec 31, 2024 | -4.23 Mn |
| Dec 31, 2024 | -4.23 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Sep 30, 2024 | 5.02 Mn |